Patent: 9,939,385
✉ Email this page to a colleague
Summary for Patent: 9,939,385
Title: | Systems, methods, and test kits for analyte variation detection |
Abstract: | Systems, methods, and test kits for monitoring and detecting variation in an analyte level in a fluid sample from an individual variation using a uniquely determined analyte threshold value. In one implementation, luteinizing hormone is the monitored analyte and is compared with the determined threshold value to predict the onset of ovulation for the individual. |
Inventor(s): | Nazareth; Albert (Mercerville, NJ), Sturman; Andy (San Diego, CA), Zin; Benedict (San Diego, CA), Cheng; Yea-Shun (Doylestown, PA), Bell; Henry (Hamilton Square, NJ), Li; Shang (West Windsor, NJ) |
Assignee: | Church & Dwight Co., Inc. (Princeton, NJ) |
Application Number: | 13/229,156 |
Patent Claims: | see list of patent claims |
Details for Patent 9,939,385
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2040-03-31 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2040-03-31 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2040-03-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |